The state-independent RyR2 blocker tetracaine (TET) was less effective in suppressing spontaneous Ca2+ release in CPVT myocytes [21, 22], suggesting that the state-dependent mode of drug action may contribute to the drug efficacy in CPVT. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.